Ad is loading...
ABCL
Price
$3.01
Change
+$0.01 (+0.33%)
Updated
Nov 29 closing price
85 days until earnings call
ARCT
Price
$18.34
Change
+$0.83 (+4.74%)
Updated
Nov 29 closing price
Ad is loading...

ABCL vs ARCT

Header iconABCL vs ARCT Comparison
Open Charts ABCL vs ARCTBanner chart's image
AbCellera Biologics
Price$3.01
Change+$0.01 (+0.33%)
Volume$2.44M
CapitalizationN/A
Arcturus Therapeutics Holdings
Price$18.34
Change+$0.83 (+4.74%)
Volume$201.91K
CapitalizationN/A
ABCL vs ARCT Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABCL vs. ARCT commentary
Dec 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ARCT is a Hold.

COMPARISON
Comparison
Dec 02, 2024
Stock price -- (ABCL: $3.01 vs. ARCT: $18.34)
Brand notoriety: ABCL and ARCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 113% vs. ARCT: 52%
Market capitalization -- ABCL: $889.05M vs. ARCT: $496.78M
ABCL [@Biotechnology] is valued at $889.05M. ARCT’s [@Biotechnology] market capitalization is $496.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.43B to $0. The average market capitalization across the [@Biotechnology] industry is $2.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileARCT’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ARCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while ARCT’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 3 bearish.
  • ARCT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +9.06% price change this week, while ARCT (@Biotechnology) price change was +8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.34%. For the same industry, the average monthly price growth was +2.50%, and the average quarterly price growth was +11.52%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

ARCT is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+6.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($889M) has a higher market cap than ARCT($497M). ARCT YTD gains are higher at: -41.833 vs. ABCL (-47.285). ARCT has higher annual earnings (EBITDA): -25.93M vs. ABCL (-202.4M). ABCL has more cash in the bank: 643M vs. ARCT (237M). ARCT has less debt than ABCL: ARCT (29.4M) vs ABCL (71.4M). ARCT has higher revenues than ABCL: ARCT (142M) vs ABCL (33M).
ABCLARCTABCL / ARCT
Capitalization889M497M179%
EBITDA-202.4M-25.93M781%
Gain YTD-47.285-41.833113%
P/E RatioN/AN/A-
Revenue33M142M23%
Total Cash643M237M271%
Total Debt71.4M29.4M243%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLARCT
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRTIX17.640.23
+1.32%
T. Rowe Price International Value Eq I
FASOX59.880.20
+0.34%
Fidelity Advisor Value Strategies I
MMQLX9.730.02
+0.21%
MassMutual Small Cap Val Eq Adm
TRMNX22.640.02
+0.09%
T. Rowe Price Mid-Cap Index
DLRHX27.370.02
+0.07%
Delaware Healthcare R

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+0.33%
VCYT - ABCL
56%
Loosely correlated
+0.14%
PRME - ABCL
54%
Loosely correlated
-0.30%
DNA - ABCL
54%
Loosely correlated
+5.33%
BEAM - ABCL
54%
Loosely correlated
+0.63%
ADPT - ABCL
53%
Loosely correlated
+3.66%
More

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with ABCL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+4.74%
ABCL - ARCT
49%
Loosely correlated
+0.33%
AXON - ARCT
49%
Loosely correlated
+1.89%
BMEA - ARCT
46%
Loosely correlated
+3.13%
PGEN - ARCT
45%
Loosely correlated
+2.50%
BEAM - ARCT
44%
Loosely correlated
+0.63%
More